Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
The chromatin remodeler p400 ATPase facilitates Rad51-mediated repair of DNA double-strand breaks.
Courilleau C, Chailleux C, Jauneau A, Grimal F, Briois S, Boutet-Robinet E, Boudsocq F, Trouche D, Canitrot Y.
J Cell Biol. 2012 Dec 24;199(7):1067-81. doi: 10.1083/jcb.201205059.
Related citations
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivity.
Budke B, Kalin JH, Pawlowski M, Zelivianskaia AS, Wu M, Kozikowski AP, Connell PP.
J Med Chem. 2013 Jan 10;56(1):254-63. doi: 10.1021/jm301565b. Epub 2012 Dec 26.
Sensitization of tumor to ²¹²Pb radioimmunotherapy by gemcitabine involves initial abrogation of G2 arrest and blocked DNA damage repair by interference with Rad51.
Yong KJ, Milenic DE, Baidoo KE, Brechbiel MW.
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):1119-26. doi: 10.1016/j.ijrobp.2012.09.015. Epub 2012 Nov 29.
RAD51 gene polymorphisms and sporadic colorectal cancer risk in Poland.
Romanowicz-Makowska H, Samulak D, Michalska M, Sporny S, Langner E, Dziki A, Sychowski R, Smolarz B.
Pol J Pathol. 2012 Nov;63(3):193-8.
Rad51 paralog complexes BCDX2 and CX3 act at different stages in the BRCA1-BRCA2-dependent homologous recombination pathway.
Chun J, Buechelmaier ES, Powell SN.
Mol Cell Biol. 2013 Jan;33(2):387-95. doi: 10.1128/MCB.00465-12. Epub 2012 Nov 12.
A single nucleotide polymorphism in the 5' untranslated region of RAD51 and ovarian cancer risk in Polish women.
Romanowicz-Makowska H, Smolarz B, Samulak D, Michalska M, Lewy J, Burzyński M, Kokołaszwili G.
Eur J Gynaecol Oncol. 2012;33(4):406-10.
HSP90 inhibition induces cytotoxicity via down-regulation of Rad51 expression and DNA repair capacity in non-small cell lung cancer cells.
Ko JC, Chen HJ, Huang YC, Tseng SC, Weng SH, Wo TY, Huang YJ, Chiu HC, Tsai MS, Chiou RY, Lin YW.
Regul Toxicol Pharmacol. 2012 Dec;64(3):415-24. doi: 10.1016/j.yrtph.2012.10.003. Epub 2012 Oct 13.
Lack of association between the 135G/C RAD51 gene polymorphism and the risk of colorectal cancer among Polish population.
Mucha B, Przybyłowska-Sygut K, Dziki L, Dziki A, Sygut A, Majsterek I.
Pol Przegl Chir. 2012 Jul;84(7):358-62. doi: 10.2478/v10035-012-0060-x.
RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the absence of BRCA1 and 53BP1.
Nakada S, Yonamine RM, Matsuo K.
Cancer Res. 2012 Oct 1;72(19):4974-83. doi: 10.1158/0008-5472.CAN-12-1057. Epub 2012 Aug 3.
A distinct replication fork protection pathway connects Fanconi anemia tumor suppressors to RAD51-BRCA1/2.
Schlacher K, Wu H, Jasin M.
Cancer Cell. 2012 Jul 10;22(1):106-16. doi: 10.1016/j.ccr.2012.05.015.
RAD51 mutants cause replication defects and chromosomal instability.
Kim TM, Ko JH, Hu L, Kim SA, Bishop AJ, Vijg J, Montagna C, Hasty P.
Mol Cell Biol. 2012 Sep;32(18):3663-80. doi: 10.1128/MCB.00406-12. Epub 2012 Jul 9.
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition.
Wang Y, Huang JW, Calses P, Kemp CJ, Taniguchi T.
Cancer Res. 2012 Aug 15;72(16):4037-46. doi: 10.1158/0008-5472.CAN-12-0103. Epub 2012 Jul 3.
Suberoylanilide hydroxamic acid as a radiosensitizer through modulation of RAD51 protein and inhibition of homology-directed repair in multiple myeloma.
Chen X, Wong P, Radany EH, Stark JM, Laulier C, Wong JY.
Mol Cancer Res. 2012 Aug;10(8):1052-64. doi: 10.1158/1541-7786.MCR-11-0587. Epub 2012 Jun 22.
A variant of the breast cancer type 2 susceptibility protein (BRC) repeat is essential for the RECQL5 helicase to interact with RAD51 recombinase for genome stabilization.
Islam MN, Paquet N, Fox D 3rd, Dray E, Zheng XF, Klein H, Sung P, Wang W.
J Biol Chem. 2012 Jul 6;287(28):23808-18. doi: 10.1074/jbc.M112.375014. Epub 2012 May 29.
Role of the RAD51 G172T polymorphism in the clinical outcome of cervical cancer patients under concomitant chemoradiotherapy.
Nogueira A, Catarino R, Faustino I, Nogueira-Silva C, Figueiredo T, Lombo L, Hilário-Silva I, Pereira D, Medeiros R.
Gene. 2012 Aug 10;504(2):279-83. doi: 10.1016/j.gene.2012.05.037. Epub 2012 May 24.
Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer.
Gresner P, Gromadzinska J, Polanska K, Twardowska E, Jurewicz J, Wasowicz W.
Gene. 2012 Aug 10;504(2):166-74. doi: 10.1016/j.gene.2012.05.030. Epub 2012 May 18.
The association between polymorphisms of the RAD51-G135C, XRCC2-Arg188His and XRCC3-Thr241Met genes and clinico-pathologic features in breast cancer in Poland.
Romanowicz-Makowska H, Smolarz B, Zadrozny M, Westfa B, Baszczyński J, Kokołaszwili G, Burzyfiski M, Połać I, Sporny S.
Eur J Gynaecol Oncol. 2012;33(2):145-50.
HSF4 is involved in DNA damage repair through regulation of Rad51.
Cui X, Zhang J, Du R, Wang L, Archacki S, Zhang Y, Yuan M, Ke T, Li H, Li D, Li C, Li DW, Tang Z, Yin Z, Liu M.
Biochim Biophys Acta. 2012 Aug;1822(8):1308-15. doi: 10.1016/j.bbadis.2012.05.005. Epub 2012 May 14.
RI-1: a chemical inhibitor of RAD51 that disrupts homologous recombination in human cells.
Budke B, Logan HL, Kalin JH, Zelivianskaia AS, Cameron McGuire W, Miller LL, Stark JM, Kozikowski AP, Bishop DK, Connell PP.
Nucleic Acids Res. 2012 Aug;40(15):7347-57. doi: 10.1093/nar/gks353. Epub 2012 May 9.
Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.
Wilk A, Waligorska A, Waligorski P, Ochoa A, Reiss K.
PLoS One. 2012;7(3):e33867. doi: 10.1371/journal.pone.0033867. Epub 2012 Mar 16.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on